5980 Horton Street
Trianni is a privately held organization formed in 2010 with a mission to leverage recent advances in DNA synthesis and genomic modification technology toward development of an optimized therapeutic antibody discovery platform - The Trianni Mouse. The company is headquartered in the San Francisco Bay Area (CA, USA). For more information, please visit www.trianni.com.
Cofounder: Matthias Wabl, PhD